How Long Can a Person Live on Dialysis With Kidney Failure?

Life expectancy on dialysis varies enormously depending on age, overall health, and the type of dialysis used, but it typically ranges from a few years for older adults with multiple chronic conditions to a decade or more for younger, otherwise healthy patients. A 50-year-old starting dialysis in the United States can expect to live roughly eight additional years on average, though that figure masks wide variation in both directions.¹ The honest answer is that no single number captures the reality, because the factors that shorten or extend life on dialysis are numerous and interact in ways that make each person’s outlook quite individual.

What the Average Numbers Actually Look Like

When researchers compare dialysis patients to people of the same age without kidney failure, the gap is sobering. A study using Medicare data found that patients who start dialysis at ages 66 to 70 have a survival profile roughly equivalent to adults in the general population who are 86 to 90 years old. For patients who begin dialysis at 76 to 80, their five-year survival resembles that of people in their early 90s. Only about a third of older adults with kidney failure survive five years once treatment begins.² Those numbers sound grim, but they include many patients who arrive at dialysis already quite sick. Younger patients and those with fewer other health problems routinely survive well beyond that average.

It is also worth knowing that survival on dialysis has improved over the decades, but not as quickly as survival in the general population. Between 1977 and 2007, life expectancy for a 50-year-old starting dialysis rose by about 8%, from 7.3 to 7.9 years. Over the same period, life expectancy for a 50-year-old in the general U.S. population rose 12%. So while dialysis patients are living somewhat longer, the gap between them and everyone else has actually widened.¹

Age Is the Single Biggest Factor

No variable predicts dialysis survival more reliably than the age at which you start. Patients over 65 have a death rate roughly three times higher than younger patients on hemodialysis.³ That difference is not surprising when you consider that older patients almost always arrive with more cardiovascular disease, more diabetes, and less physical reserve. A 30-year-old on dialysis can realistically expect to live 15 to 20 years or longer, while an 80-year-old might measure remaining life in months to a few years.

Race and ethnicity add a layer of complexity. In the general U.S. population, Black Americans have higher rates of death from most causes. On dialysis, the relationship flips: Black patients consistently survive longer than white patients. One study found that mortality was significantly lower for Black patients across virtually every age group above 30, with hazard ratios ranging from 0.70 to 0.87 compared to non-Hispanic white patients.⁴ Hispanic patients showed even lower mortality across all ages. This reversal, sometimes called the dialysis survival paradox, persists even after adjusting for other health conditions and has been documented repeatedly across large registries.⁵ Researchers have proposed explanations involving differences in inflammation, nutrition, and body composition, but the paradox remains only partially understood.

The Dangerous First 90 Days

One of the least-discussed realities of dialysis is that the riskiest period comes right at the beginning. The first three months after starting dialysis carry a death rate nearly double what it is afterward.⁶ Data from the U.S., Canadian, and European registries all converge on the same pattern: deaths in the first 90 days account for about 35 to 36% of all deaths in the first year.⁷

A closer look at U.S. hemodialysis patients confirmed that the death rate in the first and second months was roughly 80% higher than among patients who had been on dialysis for several months, and it did not settle down to the “baseline” rate until about the seventh month.⁸ Part of the explanation is that many patients start dialysis in crisis, arriving at the emergency department with fluid overload or dangerously high potassium rather than transitioning gradually. The body also needs time to adjust to the dramatic fluid and electrolyte shifts that dialysis imposes. If you or someone you know is about to start dialysis, knowing that these early months are especially hazardous can encourage closer monitoring and a smoother transition.

Diabetes, Heart Disease, and Other Conditions That Shorten the Timeline

Kidney failure rarely exists in isolation. Most people who reach the point of needing dialysis have been living with diabetes, high blood pressure, or heart disease for years, and those conditions continue shaping survival after dialysis begins. In one cohort of patients with type 2 diabetes starting dialysis, roughly two-thirds already had a history of acute heart failure, and about a third died within the first year, mostly from cardiovascular causes.⁹

Among diabetic patients on dialysis, the most consistent predictors of earlier death include older age, a diabetes duration greater than ten years, a history of heart failure, and existing cardiovascular disease present before dialysis even started.¹⁰ Other factors that show up as significant risks across multiple analyses include smoking, poor functional status, low blood albumin levels, and low hemoglobin.¹¹ The bottom line is that two patients of the same age can have wildly different prognoses depending on what else is going on in their body. Sudden cardiac death, rather than kidney failure itself, is the single most common cause of death in dialysis patients.¹²

Does the Type of Dialysis Matter for Survival?

There are two main forms: hemodialysis, which filters blood through a machine typically at a clinic three times a week, and peritoneal dialysis, which uses the lining of the abdomen as a natural filter and can be done at home. Patients and families often want to know if one is clearly better for longevity, and the evidence is more nuanced than a simple winner.

A large propensity-matched study found that peritoneal dialysis was associated with an 8% lower overall mortality risk compared to hemodialysis in the first couple of years. At one year, survival was about 86% for peritoneal dialysis patients versus 81% for hemodialysis patients. By three to four years, however, the difference faded and the two modalities were essentially tied.¹³ When the same study looked at subgroups, peritoneal dialysis showed a clearer advantage in patients under 65 and in those without diabetes or cardiovascular disease. For patients who did have cardiovascular disease or diabetes, hemodialysis may have the edge after the first year or two.

A more recent analysis comparing the two modalities in an era of updated Medicare payment policies found no significant difference in two-year mortality after adjusting for patient characteristics.¹⁴ The practical takeaway is that neither modality is dramatically superior for most patients, and the choice often comes down to lifestyle, convenience, and medical suitability rather than pure survival data. There is one exception worth noting: in patients with subclinical peripheral artery disease, hemodialysis was linked to better survival over six years than peritoneal dialysis, though this was a small, specific population.¹⁵

Home Dialysis and How Often You Dialyze

Beyond the hemodialysis-versus-peritoneal debate, where and how often hemodialysis happens can make a measurable difference. A large matched comparison found that daily home hemodialysis was associated with about a 13% lower risk of death compared with the standard schedule of three times per week in a clinic.¹⁶ An older national study reported an even more striking difference, with home hemodialysis patients showing an adjusted mortality risk that was roughly 40% lower than clinic-based patients.¹⁷ Some of that gap likely reflects selection bias: healthier, more motivated patients are more likely to be offered and to succeed with home dialysis. Still, more frequent and gentler treatments seem to reduce the cardiovascular stress that dialysis imposes.

The adequacy of each dialysis session also matters. Researchers measure this using a metric that captures how much waste is cleared relative to the patient’s body water. Patients receiving lower-dose dialysis have consistently higher mortality across all age groups, with the strongest effect seen in the very elderly, where inadequate dosing was linked to a roughly doubled risk of death.¹⁸ Higher-dose dialysis showed clear survival benefits for patients under 65.¹⁹

Vascular Access Can Be a Life-or-Death Decision

For hemodialysis patients, the way blood is accessed for treatment turns out to be a surprisingly powerful predictor of survival. There are three main options: an arteriovenous fistula, which is a surgically created connection between an artery and vein in the arm; a synthetic graft; and a catheter placed in a large vein, typically in the chest or neck. Fistulas are widely considered the gold standard. In a seven-year cohort study, patients using a non-tunneled catheter had five times the risk of death compared to those with a fistula, while tunneled catheters carried about 2.8 times the risk.²⁰ An older international study similarly found that catheter use raised the odds of infection-related death threefold compared with a fistula.²¹

One Italian study challenged this consensus, finding that tunneled catheters were actually associated with lower mortality in elderly patients over 75.²² This may reflect the reality that older patients with poor blood vessels sometimes do worse when pushed through fistula surgery they tolerate poorly. But across the broader evidence, getting a fistula created well in advance of starting dialysis is one of the most effective things a patient can do to improve their long-term outlook.

Residual Kidney Function and Incremental Dialysis

Even after kidney failure is diagnosed, most kidneys still produce some urine and filter a small amount of waste. This leftover capacity, called residual kidney function, turns out to be powerfully linked to survival. In hemodialysis patients, greater residual function one year into treatment was associated with substantially better outcomes, while rapid loss of residual function doubled the risk of death.²³ The same association holds in peritoneal dialysis, where residual function has been linked to better survival, fewer complications, and improved quality of life.²⁴

This has led to growing interest in “incremental” dialysis, which starts patients on fewer sessions per week (typically two instead of three) to go easier on the kidneys and preserve whatever function remains. A cohort study found that patients who started on incremental hemodialysis had roughly half the mortality risk of those on the standard three-times-weekly schedule, and they retained more residual function over time.²⁵ Another study confirmed that incremental dialysis preserved residual function without compromising survival.²⁶ Not every patient is a candidate for this approach, and it requires careful monitoring, but it represents one of the more promising strategies for extending both the length and quality of life on dialysis.

Kidney Transplant Changes the Equation Entirely

For patients who are eligible, a kidney transplant offers a dramatic improvement in life expectancy compared to staying on dialysis. A study of transplant-eligible patients found that transplantation added roughly three extra years of life within a ten-year follow-up for a 60-year-old, and about two and a half years for a 70-year-old.²⁷ Even among elderly patients considered suitable for transplant, the survival advantage is clear: one study found that listed patients who received a transplant lived an average of 8.2 years compared to 4.3 years for those who remained on dialysis.²⁸

Transplantation achieves survival gains across a wide range of ages and comorbidity levels, and it remains cost-effective even in older patients with additional health conditions.²⁹ The catch, of course, is that transplant organs are scarce. Average wait times for a deceased-donor kidney in the U.S. run several years, and not everyone is medically suitable for transplant surgery or the lifelong immunosuppression it requires. But for those who can pursue it, transplant is the intervention with the biggest impact on how long you live after kidney failure.

When Dialysis May Not Be Worth It

One of the more difficult conversations in nephrology involves older, frail patients for whom dialysis may extend life only modestly while imposing a heavy burden. A review of available studies found that any survival benefit from dialysis in elderly patients shrinks as comorbidities increase, and that it becomes genuinely uncertain whether dialysis adds meaningful time for patients with advanced heart disease.³⁰ A broader review reached the same conclusion: the survival advantage of dialysis mainly applies to younger and less frail patients, and it diminishes as frailty and multiple chronic conditions accumulate.³¹

Conservative kidney management, which focuses on symptom control and quality of life without dialysis, is a legitimate option for some patients. A recent study found that median survival from the point of choosing treatment was about 53 months for dialysis, 32 months for patients who chose conservative management but were suitable for dialysis, and 18 months for those considered less suitable for dialysis.³² Among patients over 80, the gap between dialysis and conservative management narrowed. For patients who do eventually stop dialysis, life expectancy is very short: one study found that patients who discontinued hemodialysis after an average of about 3.5 years of treatment survived an average of 9.6 days afterward.³³

The Obesity Paradox and Nutritional Markers

In the general population, obesity raises the risk of developing kidney disease in the first place. But once someone is on dialysis, the relationship between body weight and survival flips. Patients with higher body mass and more muscle mass consistently live longer on dialysis than thinner patients, a phenomenon known as the obesity paradox. Both larger muscle mass and higher body fat appear protective, while low body weight and weight loss are associated with higher mortality.³⁴ In a large hemodialysis cohort, higher BMI up to 45 was incrementally and independently associated with greater survival, even after adjusting for nutritional status and inflammation.³⁵

This does not mean dialysis patients should try to gain weight. The paradox likely reflects the devastating effect of malnutrition and wasting, which are extremely common in kidney failure. Patients who are losing weight or have low serum albumin levels are often in a state of chronic inflammation and protein depletion that accelerates decline. Maintaining adequate nutrition and preserving muscle mass is one of the more actionable things a dialysis patient can do to improve their odds.

Quality of Life as a Survival Predictor

How a patient feels on dialysis turns out to predict how long they live, independently of their lab values and medical history. The Dialysis Outcomes and Practice Patterns Study, which followed hemodialysis patients across multiple countries, found that for each ten-point decline on a physical health quality-of-life score, the adjusted risk of death rose by 25%.³⁶ Mental health scores and kidney-disease-specific quality scores also predicted mortality, though less strongly. Hospitalization risk followed a similar pattern.

This finding has practical implications. It suggests that measures to improve how patients feel on dialysis, including managing symptoms like fatigue, nausea, and cramping, treating depression, and supporting physical activity, are not just about comfort. They may genuinely extend life. Dialysis programs that prioritize patient experience and functional capacity are likely doing more for survival than their lab-focused counterparts realize.

Global Differences in Dialysis Survival

Where you live matters for dialysis outcomes in ways that go beyond individual health. International comparisons reveal significant disparities in survival between high-income and low-income countries, driven by differences in infection rates, access to medications, and healthcare infrastructure.³⁷ Even among wealthy nations, dialysis mortality varies. A cross-country analysis found that much of this variation tracked with differences in cardiovascular death rates in the general population of each country. In other words, countries where heart disease kills more people overall also see more dialysis patients dying of heart disease, suggesting that genetic and environmental factors shared by the broader population carry over into the dialysis ward.³⁸ In low-income countries, infections and social factors play a much larger role in deaths on dialysis, reflecting gaps in treatment quality rather than differences in patient biology.